Chimeric Therapeutics Limited
Chimeric Therapeutics Limited (CHMMF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CHMMF · as of Jun 9, 2026
Key Statistics
Explore Chimeric Therapeutics Limited Data
chmmf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
chmmf competitorsCHMMF
BETRF
CUBT
GLWLF
LIANY
NSHSFStock Performance
Full HistoryAbout Chimeric Therapeutics Limited
Chimeric Therapeutics Limited is an Australian biotechnology firm operating at the clinical stage, dedicated to advancing and commercializing a diverse portfolio of cell-based treatments specifically …
what is chimeric therapeutics limited · chmmf stock overview · chimeric therapeutics limited company profile · who is chimeric therapeutics limited ceo · chmmf OTC · chimeric therapeutics limited headquarters · chimeric therapeutics limited business segments
About Stock Overview & Key Data
Chimeric Therapeutics Limited (CHMMF) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 30, 2022. As of the latest trading session, CHMMF stock price is $0.10, with a market capitalization of $4.1M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2025, Chimeric Therapeutics Limited reported revenue of $4.0M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Chimeric Therapeutics Limited (CHMMF) stock price is $0.10. The stock is traded on OTC under the ticker symbol CHMMF. The 52-week range is $0.00 – $0.10.